Biosense Webster, Inc.
Clinical trials sponsored by Biosense Webster, Inc., explained in plain language.
-
New catheter combo aims to keep AFib in check longer
Disease control OngoingThis study looks at how well a special catheter (THERMOCOOL SMARTTOUCH SF) and software (Ablation Index) work to treat paroxysmal atrial fibrillation, a type of irregular heartbeat. Researchers will track 150 adults who get this procedure to see if they stay free of heart rhythm …
Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New heart device aims to cut stroke risk in AFib patients
Disease control TerminatedThis study tests a new device (Laminar) to close the left atrial appendage, a small pouch in the heart, in 1500 people with non-valvular atrial fibrillation. The goal is to see if it is safer and works better than existing devices to reduce the risk of stroke and blood clots. Par…
Phase: NA • Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New heart device could free AFib patients from blood thinners
Disease control OngoingThis early study tests a device that closes a small pouch in the heart (the left atrial appendage) in people with atrial fibrillation who cannot take blood thinners. The goal is to lower the risk of stroke without needing lifelong medication. About 58 participants will be followe…
Phase: NA • Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC